TELA BIO, INC. Key Metrics

2 years of history · ending 2025-12-31 · SEC EDGAR

Forensics

Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.

F-Score (Piotroski 0-9)

Z-Score (Altman; <1.81 = distress)

Per Share Metrics

Turnover & Efficiency Analysis (days)

Expense Ratios

Working Capital Analysis

Valuation Multiples

Enterprise Value Multiples

52-Week Range

Trailing Returns

ROIC vs WACC

Yields

Capital Deployment Yields

Liquidity & Leverage Ratios

Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)

EPS (Diluted)
$-1
Book Value Per Share
$0
Free Cash Flow Per Share
$-1
Cash Per Share
$1
Revenue Per Share
$2
OCF Per Share
$-1
Return on Equity
-223.4%
Return on Assets
-46.2%
Return on Invested Capital
-40.5%
Debt to Equity
8.82
Current Ratio
4.20
Quick Ratio
3.59
Asset Turnover
0.96
Days Payables Outstanding
32.98
Days Inventory On Hand
157.35
R&D / Revenue
11.5%
SBC / Revenue
4.7%
Capex / Revenue
0.6%
Working Capital
$58M
Net Current Asset Value
$476K
Invested Capital
$62M
OCF / Net Income
0.73
FCF / Net Income
0.74
Accruals Ratio (Sloan)
-13.0%
Net Debt
$5M
Net Debt / EBITDA
-0.15
Interest Coverage
-6.44
Cash Coverage
-5.38
Capex Coverage
-62.99
Tangible Common Equity
$5M
TCE / Total Assets
6.1%
NOPAT
$-27M
Cash ROIC
-43.6%
WC / Revenue
71.8%
Capex / D&A
0.71
Reinvestment Rate
0.5%
Asset Growth vs Revenue Growth
-21.8%
Revenue 5Y CAGR
34.5%
Book Value 5Y CAGR
-33.6%
Stock Price (FY-end)
$1
Market Cap
$55M
P/S Ratio
0.69
P/B Ratio
8.78
P/TB Ratio
11.18
Enterprise Value
$60M
EV / Sales
0.75
FCF Yield
-51.7%
Shareholder Yield
-6.9%
R&D Yield
16.6%
Capex Yield
0.8%
Shares Variation (YoY)
64.6%
Beta (5Y)
0.77
Cost of Equity
8.3%
Cost of Debt (after tax)
7.4%
WACC
7.9%
ROIC - WACC Spread
-48.4%
52W High
$3
52W Low
$1
Trailing Return 1Y
-59.5%
Trailing Return 5Y
-92.7%
F-Score (Piotroski)
3.00
Z-Score (Altman)
-5.93

Earnings Forecasts

Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).

Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.

EPS — Consensus vs Actual

Revenue — Consensus vs Actual

Stock Price on Earnings Dates